Account
Birla Opus to disrupt the Indian paints industry with DDB Mudra as creative partner
Mumbai: Birla Opus, from the house of Aditya Birla Group, has selected DDB Mudra as its creative partner for four brands in the range, following a multi-agency pitch. The mandate involves crafting strategy and communications for Birla Opus which offers a wide array of decorative paints aimed at businesses and consumers.
With this partnership, DDB Mudra will manage the comprehensive portfolio of four brands from Birla Opus: Style (economy paints range), AllWood (wood finishes), AllDry (waterproofing) and Prime (institutional).
Birla Opus head, marketing Inderpreet Singh said, “We look at our agency partners as an extension of our team, sharing similar passion and belief in the brand. Our endeavour is to make the lives of our consumers a little more colourful and prettier every day and we are pleased to have DDB Mudra as our partners in this journey.”
DDB Mudra Group president and managing partner – growth & strategy Saad Khan said, “We are delighted to be a part of the journey of Birla Opus. This is a big moment in the paint category in India. During our interactions with the team at Birla Opus, including the R&D team, we immediately felt their passion and ambition to disrupt and change the course of paint category. DDB’s DNA has always been about making challenger brands win, and we intend to come true on the creative mandate Birla Opus has given to us.”
Through this foray, Aditya Birla Group will be able to tap into a high-growth Rs. 70,000 crore decorative paints market. This category has been witnessing double digit YOY growth. Aiming to be one of the biggest players in the decorative paints industry in the coming years, the brand is committed to expanding pan-India distribution points and manufacturing units. As a flagship company of the Aditya Birla Group, Grasim will build upon a solid foundation established over the years and leverage the power and trust associated with the brand.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
